Boundless Science is developing innovative devices that will dramatically improve outcomes for patients suffering from heart and lung failure.
SUPPORTERS/INVESTORS
Financially supported by:
Discover
CLINICAL NEED
Current solutions are not effective enough to prevent approximately 800,000 deaths in the US each year due to complications of heart and lung failure.
The origins of heart and lung failure are many, and can progress over years or an afternoon, ultimately all leading to the same outcome – a hospital stay, usually in the ICU, and support by a variety of medical devices. Our goal is to reduce the complexity of care and improve outcomes for these patients.
Boundless Science is developing completely novel devices to safely and more effectively treat these patients by doing the following:
-
Reduce anticoagulation
-
Reduce hemolysis
-
Minimize blood infusions
-
Improve ease-of-use
-
Allow for patient ambulation
OUR TECHNOLOGY
Current medical devices for heart and lung failure are not good enough. Current solutions damage blood and require a complex algorithm of blood thinners which can cause significant morbidity and mortality on their own. Monitoring and adjusting their blood chemistry and blood gases is extremely complex, requiring the constant attention of a highly skilled team of clinicians in an ICU.
Boundless Science is developing a novel therapy to facilitate blood flow and oxygenation with minimal damage to the blood.